Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Knowing what to avoid in cryptocurrency investments can save you from costly errors. Stay informed to protect your assets.
15,893 articlesA tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Peloton has faced a brutal selloff, but the story isn’t finished. This article dives into whether Peloton is broken o...
A chorus of caution from michael burry, paul tudor and a Nobel-winning peer signals a potential reversal in a tech-le...
A new wave of proposals aims to tighten how decentralized finance operates in the U.S. Senate. These clarity amendmen...
With a key vote looming, the House offers carve-outs for build-to-rent and renovate-to-rent, altering a broader push ...
TriSalus investors are eyeing the Q1 2026 earnings update to gauge cash runway, pipeline progress, and milestone-driv...
Cava Group bets on fresh growth and better margins, even as the market stays wary. This piece breaks down what could ...
Retirees face rising tax headwinds as withdrawals, Social Security, and Medicare premiums stack. A shift to proactive...
BIT Capital trimmed a large Lemonade stake in the first quarter, revealing how institutional moves can influence vola...
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
AI-driven tech stocks swing in early 2026 as valuations recalibrate. Analysts say a consumer staples ETF can help hed...
AI can automate many tasks, but in crypto, on-call engineers still lead the way. This piece dives into why humans out...